287
Views
16
CrossRef citations to date
0
Altmetric
Original Research

Metagenomic Next-Generation Sequencing for Pulmonary Fungal Infection Diagnosis: Lung Biopsy versus Bronchoalveolar Lavage Fluid

ORCID Icon, , &
Pages 4333-4359 | Published online: 20 Oct 2021

References

  • Li Z, Lu G, Meng G. Pathogenic fungal infection in the lung. Front Immunol. 2019;10. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616198/.
  • Arvanitis M, Mylonakis E. Diagnosis of invasive aspergillosis: recent developments and ongoing challenges. Eur J Clin Invest. 2015;45(6):646–652. doi:10.1111/eci.1244825851301
  • Perfect JR, Cox GM, Lee JY, et al. The impact of culture isolation of Aspergillus species: a hospital‐based survey of aspergillosis. Clin Infect Dis. 2001;33(11):1824–1833. doi:10.1086/32390011692293
  • Hage CA, Carmona EM, Epelbaum O, et al. Microbiological laboratory testing in the diagnosis of fungal infections in pulmonary and critical care practice. An official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2019;200(5):535–550. doi:10.1164/rccm.201906-1185ST31469325
  • Surmont I, Stockman W. Gluconate-containing intravenous solutions: another cause of false-positive galactomannan assay reactivity. J Clin Microbiol. 2007;45(4):1373. doi:10.1128/JCM.02373-0617287325
  • Hage CA, Reynolds JM, Durkin M, Wheat LJ, Knox KS. Plasmalyte as a cause of false-positive results for Aspergillus galactomannan in bronchoalveolar lavage fluid. J Clin Microbiol. 2007;45(2):676–677. doi:10.1128/JCM.01940-0617166959
  • Racil Z, Kocmanova I, Lengerova M, Winterova J, Mayer J. Intravenous PLASMA-LYTE as a major cause of false-positive results of platelia aspergillus test for galactomannan detection in serum. J Clin Microbiol. 2007;45(9):3141–3142. doi:10.1128/JCM.00974-0717670932
  • Gu W, Miller S, Chiu CY. Clinical metagenomic next-generation sequencing for pathogen detection. Annu Rev Pathol Mech Dis. 2019;14(1):319–338. doi:10.1146/annurev-pathmechdis-012418-012751
  • Miao Q, Ma Y, Wang Q, et al. Microbiological diagnostic performance of metagenomic next-generation sequencing when applied to clinical practice. Clin Infect Dis. 2018;67(suppl_2):S231–S240. doi:10.1093/cid/ciy69330423048
  • Li Y, Sun B, Tang X, et al. Application of metagenomic next-generation sequencing for bronchoalveolar lavage diagnostics in critically ill patients. Eur J Clin Microbiol Infect Dis off Publ Eur Soc Clin Microbiol. 2020;39(2):369–374. doi:10.1007/s10096-019-03734-5
  • Zhang H-C, Ai J-W, Cui P, et al. Incremental value of metagenomic next generation sequencing for the diagnosis of suspected focal infection in adults. J Infect. 2019;79(5):419–425. doi:10.1016/j.jinf.2019.08.01231442461
  • Li H, Gao H, Meng H, et al. Detection of pulmonary infectious pathogens from lung biopsy tissues by metagenomic next-generation sequencing. Front Cell Infect Microbiol. 2018;8:205. doi:10.3389/fcimb.2018.0020529988504
  • Wang J, Han Y, Feng J. Metagenomic next-generation sequencing for mixed pulmonary infection diagnosis. BMC Pulm Med. 2019;19(1):252. doi:10.1186/s12890-019-1022-431856779
  • Meyer KC, Raghu G, Baughman RP, et al. An official American Thoracic Society Clinical Practice Guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med. 2012;185(9):1004–1014. doi:10.1164/rccm.201202-0320ST22550210
  • Huang J, Jiang E, Yang D, et al. Metagenomic next-generation sequencing versus traditional pathogen detection in the diagnosis of peripheral pulmonary infectious lesions. Infect Drug Resist. 2020;13:567–576. doi:10.2147/IDR.S23518232110067
  • Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinforma Oxf Engl. 2009;25(14):1754–1760. doi:10.1093/bioinformatics/btp324
  • Wang J, Xu H, Li Z, et al. Pathogens in patients with granulomatous lobular mastitis. Int J Infect Dis. 2019;81:123–127. doi:10.1016/j.ijid.2019.01.03430685592
  • Donnelly JP, Chen SC, Kauffman CA, et al. Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the mycoses study group education and research consortium. Clin Infect Dis. 2020;71(6):1367–1376. doi:10.1093/cid/ciz100831802125
  • Li N, Cai Q, Miao Q, Song Z, Fang Y, Hu B. High‐throughput metagenomics for identification of pathogens in the clinical settings. Small Methods. 2021;5(1):2000792. doi:10.1002/smtd.20200079233614906